Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0043320160390101356
Archives of Pharmacal Research
2016 Volume.39 No. 10 p.1356 ~ p.1369
QSAR modeling to design selective histone deacetylase 8 (HDAC8) inhibitors
Cao Guang Ping

Thangapandian Sundarapandian
Son Min-Ky
Kumar Raj
Choi Yeung-Joon
Kim Yong-Seong
Kwon Yong-Jung
Kim Hyong-Ha
Suh Jung-Keun
Lee Keun-Woo
Abstract
HDAC8 inhibitors have become an attractive treatment for cancer. This study aimed to facilitate the identification of potential chemical scaffolds for the selective inhibition of histone deacetylase 8 (HDAC8) using in silico approaches. Non-linear QSAR classification and regression models of HDAC8 inhibitors were developed with support vector machine. Mean impact value-based sequential forward feature selection and grid search strategy were used for molecular descriptor selection and parameter optimization, respectively. The generated QSAR models were validated by leave-one-out cross validation and an external test set. The best QSAR classification model yielded 84 % of accuracy on the external test prediction and Matthews correlation coefficient is 0.69. The best QSAR regression model showed low root-mean-square error (0.63) and high squared correlation coefficient (0.53) for the test set. The validated QSAR models together with various drug-like properties, molecular docking and molecular dynamics simulation were sequentially used as a multi-step query in chemical database virtual screening. Finally, two hit compounds were discovered as new structural scaffolds which can be used for further in vitro and in vivo activity analyses. The strategy used in this study could be a promising computational strategy which can be utilized for other target drug design.
KEYWORD
Histone deacetylases 8, QSAR, Support vector machine, Molecular docking, Molecular dynamics simulation, Virtual screening
FullTexts / Linksout information
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI)